When attached to supporting electronics, the sensor can wirelessly transmit data to the user’s cell phone through Bluetooth.
One feature of the COVID-19 virus that makes it so difficult to contain is that it can be easily spread to others by a person who has yet to show any signs of infection. The carrier of the virus might feel perfectly well and go about their daily business–taking the virus with them to work, to the home of a family member, or to public gatherings.
A crucial part of the global effort to stem the spread of the pandemic, therefore, is the development of tests that can rapidly identify infections in people who are not yet symptomatic.
Now, Caltech researchers have developed a new type of multiplexed test (a test that combines multiple kinds of data) with a low-cost sensor that may enable the at-home diagnosis of a COVID infection through rapid analysis of small volumes of saliva or blood, without the involvement of a medical professional, in less than 10 minutes.
The research was conducted in the lab of Wei Gao, assistant professor in the Andrew and Peggy Cherng department of medical engineering.. Previously, Gao and his team have developed wireless sensors that can monitor conditions such as gout, as well as stress levels, through the detection of extremely low levels of specific compounds in blood, saliva, or sweat.
Gao’s sensors are made of graphene, a sheet-like form of carbon. A plastic sheet etched with a laser generates a 3D graphene structure with tiny pores. Those pores create a large amount of surface area on the sensor, which makes it sensitive enough to detect, with high accuracy, compounds that are only present in very small amounts. In this sensor, the graphene structures are coupled with antibodies, immune system molecules that are sensitive to specific proteins, like those on the surface of a COVID virus, for example.
Previous versions of the sensor were impregnated with antibodies for the hormone cortisol, which is associated with stress, and uric acid, which at high concentrations causes gout. The new version of the sensor, which Gao has named SARS-CoV-2 RapidPlex, contains antibodies and proteins that allow it to detect the presence of the virus itself; antibodies created by the body to fight the virus; and chemical markers of inflammation, which indicate the severity of the COVID-19 infection.
“This is the only telemedicine platform I’ve seen that can give information about the infection in three types of data with a single sensor,” Gao says. “In as little as a few minutes, we can simultaneously check these levels, so we get a full picture about the infection, including early infection, immunity, and severity.”
Established COVID-testing technologies usually take hours or even days to produce results. Those technologies also require expensive, complicated equipment, whereas Gao’s system is simple and compact.
So far, the device has been tested only in the lab with a small number of blood and saliva samples obtained for medical research purposes from individuals who have tested positive or negative for COVID-19. Though preliminary results indicate that the sensor is highly accurate, a larger-scale test with real-world patients rather than laboratory samples must be performed, Gao cautions, to definitively determine its accuracy.
With the pilot study now completed, Gao next plans to test how long the sensors last with regular use, and to begin testing them with hospitalized COVID-19 patients. Following in-hospital testing, he would like to study the suitability of the tests for in-home use. Following testing, the device will need to receive regulatory approval before it is available for widespread use at home.
“Our ultimate aim really is home use,” he says. “In the following year, we plan to mail them to high-risk individuals for at-home testing. And in the future, this platform could be modified for other types of infectious disease testing at home.”
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
- Global Handheld VOC Gas Detector Market Top Company Profile 2021| REA Systems, Ion Science, Thermo Fisher, Skyeagleeon January 20, 2021 at 3:44 am
Marketdesk added versatile composition of research derivatives pertaining to diverse | eTurboNews | Trends | Travel News Online | ...
- Philly opens COVID-19 vaccine access to some frontline workers, seniorson January 19, 2021 at 9:18 pm
Philadelphia will immediately broaden COVID-19 vaccination eligibility to essential workers, seniors over the age of 75 and people with certain high-risk conditions. Phase 1B of the city's vaccination ...
- Loss of smell from COVID-19 can create danger in your homeon January 19, 2021 at 6:54 pm
A house in Waco Texas caught fire recently, and the family inside could not smell the smoke because they had COVID-19. Luckily, they are all still alive, but what can you do to prevent something ...
- Optical Detector Market Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts to 2026on January 19, 2021 at 2:18 am
Final Report will add the analysis of the impact of COVID-19 on this industry." Global "Optical Detector Market" ...
- Global Foundry Market In India 2020-2024: COVID-19 Analysis, Drivers, Restraints, Opportunities, and Threats - Technavioon January 18, 2021 at 10:52 pm
Technavio has announced its latest market research report titled Foundry Market in India 2020-2024 (Graphic: Business Wire) LONDON-- ( BUSINESS WIRE )--The foundry market in India is expected to grow ...
Go deeper with Google Headlines on:
Go deeper with Bing News on:
Rapid detection of COVID-19
- Health experts call for aggressive Covid-19 tests after detection of UK varianton January 20, 2021 at 12:09 am
Health experts are calling for a more aggressive Covid-19 testing to reduce transmission of the virus, following the detection in the Philippines of a more infectious Covid-19 ...
- Abbott's COVID-19 antigen test may help with faster detection, isolation - CDCon January 19, 2021 at 6:04 pm
Abbott Laboratories' rapid COVID-19 antigen test is highly likely to correctly detect if people have ever contracted the virus and could help with earlier isolation, according to the U.S. Centers for ...
- Menon Announces Advancement of Trials on Rapid COVID-19 Test at the University of California San Diegoon January 19, 2021 at 7:57 am
PRNewswire/ -- Menon Biosensors, Inc. ('Menon' or the 'Company'), a distributive technology portfolio company, ...
- Eurobio Scientific expands its range of COVID-19 tests with an antigenic rapid teston January 18, 2021 at 8:45 am
Eurobio Scientific (FR0013240934, ALERS, PEA-PME eligible), a leading French group in in vitro medical diagnostics and life-sciences, today announces that its entire range of COVID-19 tests, that ...
- University of Utah professor develops rapid, portable COVID-19 test for competitionon January 17, 2021 at 4:56 am
Azar's rapid test is a small electronic device that can detect the presence of SARS-CoV-2 through a user's breath or a drop of saliva and delivers results in less than a minute.